Orfanos CE - Search Results

1

Proliferation of human melanoma cells is under tight control of protein kinase C alpha.

Krasagakis K, Lindschau C, Fimmel S, Eberle J, Quass P, Haller H, Orfanos CE. Krasagakis K, et al. Among authors: orfanos ce. J Cell Physiol. 2004 Jun;199(3):381-7. doi: 10.1002/jcp.10434. J Cell Physiol. 2004. PMID: 15095285

2

Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.

Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE. Krasagakis K, et al. Among authors: orfanos ce. Int J Oncol. 2002 Apr;20(4):865-71. Int J Oncol. 2002. PMID: 11894137

3

Desensitization of melanoma cells to autocrine TGF-beta isoforms.

Krasagakis K, Krüger-Krasagakes S, Fimmel S, Eberle J, Thölke D, von der Ohe M, Mansmann U, Orfanos CE. Krasagakis K, et al. Among authors: orfanos ce. J Cell Physiol. 1999 Feb;178(2):179-87. doi: 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5. J Cell Physiol. 1999. PMID: 10048582

4

Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.

Fecker LF, Eberle J, Orfanos CE, Geilen CC. Fecker LF, et al. Among authors: orfanos ce. J Invest Dermatol. 2002 Jun;118(6):1019-25. doi: 10.1046/j.1523-1747.2002.01744.x. J Invest Dermatol. 2002. PMID: 12060397 Free article.

5

Endothelin-1 decreases basic apoptotic rates in human melanoma cell lines.

Eberle J, Fecker LF, Orfanos CE, Geilen CC. Eberle J, et al. Among authors: orfanos ce. J Invest Dermatol. 2002 Sep;119(3):549-55. doi: 10.1046/j.1523-1747.2002.01848.x. J Invest Dermatol. 2002. PMID: 12230494 Free article.

6

The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induced apoptosis of normal human melanocytes.

Shang J, Eberle J, Geilen CC, Hossini AM, Fecker LF, Orfanos CE, Tebbe B. Shang J, et al. Among authors: orfanos ce. Skin Pharmacol Appl Skin Physiol. 2002 Sep-Oct;15(5):321-9. doi: 10.1159/000064536. Skin Pharmacol Appl Skin Physiol. 2002. PMID: 12239426

7

Conditional expression of exogenous Bcl-X(S) triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts.

Hossini AM, Eberle J, Fecker LF, Orfanos CE, Geilen CC. Hossini AM, et al. Among authors: orfanos ce. FEBS Lett. 2003 Oct 23;553(3):250-6. doi: 10.1016/s0014-5793(03)01017-2. FEBS Lett. 2003. PMID: 14572633 Free article.

8

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.

Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE, Geilen CC. Eberle J, et al. Among authors: orfanos ce. Oncogene. 2003 Dec 11;22(57):9131-41. doi: 10.1038/sj.onc.1207228. Oncogene. 2003. PMID: 14668794

9

Growth control of melanoma cells and melanocytes by cytokines.

Krasagakis K, Garbe C, Zouboulis CC, Orfanos CE. Krasagakis K, et al. Among authors: orfanos ce. Recent Results Cancer Res. 1995;139:169-82. doi: 10.1007/978-3-642-78771-3_12. Recent Results Cancer Res. 1995. PMID: 7597288 Review.

10

Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.

Krasagakis K, Garbe C, Eberle J, Orfanos CE. Krasagakis K, et al. Among authors: orfanos ce. Arch Dermatol Res. 1995;287(3-4):259-65. doi: 10.1007/BF01105076. Arch Dermatol Res. 1995. PMID: 7598530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page